Nyström HF, Jansson S, Berg G. Incidence rate and clinical features of hyperthyroidism in a long-term iodine sufficient area of Sweden (Gothenburg) 2003–2005. Clinical Endocrinology. 2013;78(5):768–76.

Article  PubMed  Google Scholar 

Holm IA, Manson JE, Michels KB, Alexander EK, Willett WC, Utiger RD. Smoking and other lifestyle factors and the risk of Graves’ hyperthyroidism. Arch Intern Med. 2005;165(14):1606–11. https://doi.org/10.1001/archinte.165.14.1606. PMID: 16043678.

Article  PubMed  Google Scholar 

Conrad N, Misra S, Verbakel JY, Verbeke G, Molenberghs G, Taylor PN, Mason J, Sattar N, McMurray JJV, McInnes IB, Khunti K, Cambridge G. Incidence, prevalence, and co-occurrence of autoimmune disorders over time and by age, sex, and socioeconomic status: a population-based cohort study of 22 million individuals in the UK. Lancet. 2023;S0140–6736(23):00457–9. https://doi.org/10.1016/S0140-6736(23)00457-9. PMID: 37156255.

Article  Google Scholar 

McLeod DS, Caturegli P, Cooper DS, Matos PG, Hutfless S. Variation in rates of autoimmune thyroid disease by race/ethnicity in US military personnel. JAMA. 2014;311(15):1563–5. https://doi.org/10.1001/jama.2013.285606. PMID: 24737370.

Article  PubMed  CAS  Google Scholar 

Brix TH, Kyvik KO, Christensen K, Hegedüs L. Evidence for a major role of heredity in Graves’ disease: A population-based study of two Danish twin cohorts. J Clin Endocrinol Metabol. 2001;86(2):930–4.

CAS  Google Scholar 

Skov J, Eriksson D, Kuja-Halkola R, Höijer J, Gudbjörnsdottir S, Svensson AM, Magnusson PKE, Ludvigsson JF, Kämpe O, Bensing S. Co-aggregation and heritability of organ-specific autoimmunity: a population-based twin study. Eur J Endocrinol. 2020;182(5):473–80. https://doi.org/10.1530/EJE-20-0049. 32229696.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Stenszky V, Kozma L, Balázs C, Rochlitz S, Bear JC, Farid NR. The genetics of Graves’ disease: HLA and disease susceptibility. J Clin Endocrinol Metab. 1985;61(4):735–40. https://doi.org/10.1210/jcem-61-4-735. PMID: 3861611.

Article  PubMed  CAS  Google Scholar 

Vaidya B, Kendall-Taylor P, Pearce SH. The genetics of autoimmune thyroid disease. J Clin Endocrinol Metab. 2002;87(12):5385–97. https://doi.org/10.1210/jc.2002-020492. PMID: 12466323.

Article  PubMed  CAS  Google Scholar 

Vyse TJ, Todd JA. Genetic analysis of autoimmune disease. Cell. 1996;85(3):311–8. https://doi.org/10.1016/s0092-8674(00)81110-1. PMID: 8616887.

Article  PubMed  CAS  Google Scholar 

Strieder TGA, Tijssen JGP, Wenzel BE, Endert E, Wiersinga WM. Prediction of progression to overt hypothyroidism or hyperthyroidism in female relatives of patients with autoimmune thyroid disease using the thyroid events Amsterdam (THEA) score. Arch Internal Med. 2008;168(15):1657–63.

Article  Google Scholar 

Song H, Fang F, Tomasson G, Arnberg FK, Mataix-Cols D, Fernández de la Cruz L, Almqvist C, Fall K, Valdimarsdóttir UA. Association of Stress-Related Disorders With Subsequent Autoimmune Disease. JAMA 2018;319(23):2388-2400.

Vestergaard P. Smoking and thyroid disorders–a meta-analysis. Eur J Endocrinol. 2002;146(2):153–61. https://doi.org/10.1530/eje.0.1460153. PMID: 11834423.

Article  PubMed  CAS  Google Scholar 

Bülow Pedersen I, Knudsen N, Jørgensen T, Perrild H, Ovesen L, Laurberg P. Large differences in incidences of overt hyper- and hypothyroidism associated with a small difference in iodine intake: a prospective comparative register-based population survey. J Clin Endocrinol Metab. 2002;87(10):4462–9. https://doi.org/10.1210/jc.2002-020750. PMID: 12364419.

Article  PubMed  CAS  Google Scholar 

Limbach M, Saare M, Tserel L, Kisand K, Eglit T, Sauer S, et al. Epigenetic profiling in CD4+ and CD8+ T cells from Graves’ disease patients reveals changes in genes associated with T cell receptor signaling. J Autoimmun. 2016;67:46–56.

Article  PubMed  CAS  Google Scholar 

Cai TT, Muhali FS, Song RH, Qin Q, Wang X, Shi LF, et al. Genome-wide DNA methylation analysis in Graves’ disease. Genomics. 2015;105:204–10. https://doi.org/10.1016/j.ygeno.2015.01.001.

Article  PubMed  CAS  Google Scholar 

Xin Z, Hua L, Shi TT, Tuo X, Yang FY, Li Y, Cao X, Yang JK. A genome-wide DNA methylation analysis in peripheral blood from patients identifies risk loci associated with Graves' orbitopathy. J Endocrinol Invest 2018;41(6):719-727. https://doi.org/10.1007/s40618-017-0796-6. PMID: 29190000.

Shi TT, Hua L, Xin Z, Li Y, Liu W, Yang YL. Identifying and Validating Genes with DNA Methylation Data in the Context of Biological Network for Chinese Patients with Graves' Orbitopathy. Int J Endocrinol 2019;2019:6212681. https://doi.org/10.1155/2019/6212681. PMID: 31001336.

Grumet FC, Payne RO, Kinishi J, Kriss JP. HL A antigens as markers for disease susceptibility and autoimmunity in Grave’s disease. Journal of Clinical Endocrinology and Metabolism. 1974;39(6):1115–9.

Article  PubMed  CAS  Google Scholar 

Yanagawa T, Mangklabruks A, Chang YB, Okamoto Y, Fisfalen ME, Curran PG, et al. Human histocompatibility leukocyte antigen-DQA1*0501 allele associated with genetic susceptibility to graves’ disease in a caucasian population. Journal of Clinical Endocrinology and Metabolism. 1993;76(6):1569–74.

PubMed  CAS  Google Scholar 

Heward JM, Allahabadia A, Daykin J, Carr-Smith J, Daly A, Armitage M, et al. Linkage disequilibrium between the human leukocyte antigen class II region of the major histocompatibility complex and Graves’ disease: Replication using a population case control and family-based study. Journal of Clinical Endocrinology and Metabolism. 1998;83(10):3394–7.

PubMed  CAS  Google Scholar 

Katahira M, Ogata H, Takashima H, Ito T, Hodai Y, Miwata T, Goto M, Yamaguchi M, Mizoguchi A, Kawakubo M, Nakamura S. Critical amino acid variants in HLA-DRB1 allotypes in the development of Graves’ disease and Hashimoto’s thyroiditis in the Japanese population. Hum Immunol. 2021;82(4):226–31.

Article  PubMed  CAS  Google Scholar 

Ueda S, Oryoji D, Yamamoto K, Noh JY, Okamura K, Noda M, Kashiwase K, Kosuga Y, Sekiya K, Inoue K, Yamada H, Oyamada A, Nishimura Y, Yoshikai Y, Ito K, Sasazuki T. Identification of independent susceptible and protective HLA alleles in Japanese autoimmune thyroid disease and their epistasis. J Clin Endocrinol Metab. 2014;99(2):E379-83.

Article  PubMed  CAS  Google Scholar 

Park MH, Park YJ, Song EY, Park H, Kim TY, Park DJ, Park KS, Cho BY. Association of HLA-DR and -DQ genes with Graves disease in Koreans. Hum Immunol. 2005;66(6):741–7.

Article  PubMed  CAS  Google Scholar 

Wongsurawat T, Nakkuntod J, Charoenwongse P, Snabboon T, Sridama V, Hirankarn N. The association between HLA class II haplotype with Graves’ disease in Thai population. Tissue Antigens. 2006;67(1):79–83.

Article  PubMed  CAS  Google Scholar 

Ban Y, Davies TF, Greenberg DA, Concepcion ES, Osman R, Oashi T, Tomer Y. Arginine at position 74 of the HLA-DR beta1 chain is associated with Graves’ disease. Genes Immun. 2004;5(3):203–8.

Article  PubMed  CAS  Google Scholar 

Yanagawa T, Hidaka Y, Guimaraes V, Soliman M, DeGroot LJ. CTLA-4 gene polymorphism associated with Graves’ disease in a Caucasian population. J Clin Endocrinol Metab. 1995;80(1):41–5.

PubMed  CAS  Google Scholar 

Kavvoura FK, Akamizu T, Awata T, Ban Y, Chistiakov DA, Frydecka I, Ghaderi A, Gough SC, Hiromatsu Y, Ploski R, Wang PW, Ban Y, Bednarczuk T, Chistiakova EI, Chojm M, Heward JM, Hiratani H, Juo SH, Karabon L, Katayama S, Kurihara S, Liu RT, Miyake I, Omrani GH, Pawlak E, Taniyama M, Tozaki T, Ioannidis JP. Cytotoxic T-lymphocyte associated antigen 4 gene polymorphisms and autoimmune thyroid disease: a meta-analysis. J Clin Endocrinol Metab. 2007;92(8):3162–70.

Article  PubMed  CAS  Google Scholar 

Vaidya B, Imrie H, Perros P, Dickinson J, McCarthy MI, Kendall-Taylor P, Pearce SH. Cytotoxic T lymphocyte antigen-4 (CTLA-4) gene polymorphism confers susceptibility to thyroid associated orbitopathy. Lancet. 1999;354(9180):743–4.

Article  PubMed  CAS  Google Scholar 

Bottini N, Musumeci L, Alonso A, Rahmouni S, Nika K, Rostamkhani M, MacMurray J, Meloni GF, Lucarelli P, Pellecchia M, Eisenbarth GS, Comings D, Mustelin T. A functional variant of lymphoid tyrosine phosphatase is associated with type I diabetes. Nat Genet. 2004;36(4):337–8.

Article  PubMed  CAS  Google Scholar 

Velaga MR, Wilson V, Jennings CE, Owen CJ, Herington S, Donaldson PT, Ball SG, James RA, Quinton R, Perros P, Pearce SH. The codon 620 tryptophan allele of the lymphoid tyrosine phosphatase (LYP) gene is a major determinant of Graves’ disease. J Clin Endocrinol Metab. 2004;89(11):5862–5.

Article  PubMed  CAS  Google Scholar 

Smyth D, Cooper JD, Collins JE, Heward JM, Franklyn JA, Howson JM, Vella A, Nutland S, Rance HE, Maier L, Barratt BJ, Guja C, Ionescu-Tîrgoviste C, Savage DA, Dunger DB, Widmer B, Strachan DP, Ring SM, Walker N, Clayton DG, Twells RC, Gough SC, Todd JA. Replication of an association between the lymphoid tyrosine phosphatase locus (LYP/PTPN22) with type 1 diabetes, and evidence for its role as a general autoimmunity locus. Diabetes. 2004;53(11):3020–3.

Article  PubMed  CAS  Google Scholar 

Tomer Y, Barbesino G, Greenberg DA, Concepcion ES, Davies TF. Mapping the major susceptibility loci for familial Graves’ and Hashimoto’s diseases: evidence for genetic heterogeneity and gene interactions. J Clin Endocrinol Metab. 1999;84:4656–64.

PubMed  CAS  Google Scholar 

Taylor JC, Gough SC, Hunt PJ, Brix TH, Chatterjee K, Connell JM, Franklyn JA, Hegedus L, Robinson BG, Wiersinga WM, Wass JA, Zabaneh D, Mackay I, Weetman AP. A genome-wide screen in 1119 relative pairs with autoimmune thyroid disease. J Clin Endocrinol Metab. 2006;91(2):646–53. https://doi.org/10.1210/jc.2005-0686. Epub 2005 Nov 8 PMID: 16278270.

Article  PubMed  CAS  Google Scholar 

Vaidya B, Imrie H, Perros P, Young ET, Kelly WF, Carr D, Large DM, Toft AD, McCarthy MI, Kendall-Taylor P, Pearce SH. The cytotoxic T lymphocyte antigen-4 is a major Graves’ disease locus. Hum Mol Genet. 1999;8(7):1195–9. https://doi.org/10.1093/hmg/8.7.1195. PMID: 10369864.

Article  PubMed  CAS  Google Scholar 

Tomer Y, Ban Y, Concepcion E, Barbesino G, Villanueva R, Greenberg DA, Davies TF. Common and unique susceptibility loci in Graves and Hashimoto diseases: results of whole-genome screening in a data set of 102 multiplex families. Am J Hum Genet. 2003;73(4):736-47. https://doi.org/10.1086/378588. Epub 2003 Sep 12. PMID: 12973666; PMCID: PMC1180598.

Dechairo BM, Zabaneh D, Collins J, Brand O, Dawson GJ, Green AP, et al. Association of the TSHR gene with Graves’ disease: The first disease specific locus. European Journal of Human Genetics. 2005;13(11):1223–30.

Article  PubMed  CAS